Stock

Citi’s Jim Suva: this stock is my top tech pick for 2022

Shares of Jabil Inc (NYSE: JBL) have been a disappointment for investors this year, now down nearly 15%. Moving forward, however, JBL is where you want to be, says Citi’s Jim Suva.

Suva defends his bullish view on Jabil

According to the senior tech analyst, Jabil is his top tech stock; one that he likes more than any other name that he covers. This morning on CNBC’s “TechCheck”, Suva said:

Jabil makes a lot of things for Apple as well as other companies. We simply think that hardware is here to stay, but as people get out of their homes and start to go back to work, we’re going to see a shift from consumer spending over to the corporate side.

Last month, Jabil reported its financial results for the second quarter that handily topped Wall Street expectations.

Analysts see upside to $78 in Jabil stock

The Florida-based company also cited “secular tailwinds” as it offered upbeat guidance for the current quarter. The Wall Street consensus on JBL at present is “buy” with a price target of $78 (on average) that translates to a 30% upside from here.

Also on Tuesday, medical device company SaltMed signed a manufacturing agreement with Jabil Inc.  

Other names that Suva likes in the tech space, include Apple Inc and Logitech International SA. He has a price target of $200 on the iPhone maker.

The post Citi’s Jim Suva: this stock is my top tech pick for 2022 appeared first on Invezz.

Disclaimer: MonopolyWinnersUpdates.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 MonopolyWinnersUpdates.com. All Rights Reserved.

To Top